HSP90AB1 and cancer: Because the PI3K signaling pathway is one of the most commonly activated and dysregulated pathways in cancers and many of the kinases in this pathway are dependent on HSP90 for its stabilization33, the inhibition of HSP90 could be an effective therapy.